mF International Limited Announces Pricing of Initial Public Offering
Hong Kong, April 19, 2024 (GLOBE NEWSWIRE) — mF International Limited (the “Company” or “mF International”), a Hong Kong-based experienced […]
FangDD Files 2023 Annual Report on Form 20-F
SHENZHEN, China, April 19, 2024 (GLOBE NEWSWIRE) — Fangdd Network Group Ltd. (NASDAQ: DUO) (“FangDD” or the “Company”), a customer-oriented […]
Avis Budget Group to Announce First Quarter 2024 Results on May 1st
PARSIPPANY, N.J., April 19, 2024 (GLOBE NEWSWIRE) — Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to […]
Vaxxinity Issues Shareholder Letter
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. […]
ContextLogic Completes Sale of Substantially All Operating Assets and Liabilities Associated with Wish to Qoo10
Transaction Enables Company to Preserve ~$2.7 Billion of Net Operating Losses (NOLs) Rishi Bajaj Appointed Chief Executive Officer; Four New […]
Voxtur Engages ICP Securities Inc. for Automated Market Making Services
TORONTO and TAMPA, Fla., April 19, 2024 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF), a North American […]
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic […]
Wrap Technologies Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
MIAMI, April 19, 2024 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (Nasdaq: WRAP) (“Wrap” or the “Company”), the makers of BolaWrap […]
IHT S-3 OPENS DOORS FOR DIVERSIFICATION CAPITAL INFUSION
Phoenix, AZ, April 19, 2024 (GLOBE NEWSWIRE) — InnSuites Hospitality Trust (NYSE American: IHT) IHT management announces Filing an S-3, […]
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company […]
